Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Disease area: Airway diseases

Abstract

Background: Crohn‘s Disease (CD) is an inflammatory bowel disease often associated with a variety of systemic manifestations, including airways involvement. Fractional Exhaled Nitric Oxide (FENO) can be measured non invasively at low (bronchial air) and high (alveolar air) flows to reflect proximal airway inflammation, and systemic inflammation.
The aim of our study was to compare both bronchial and alveolar FENO as an index of pulmonary involvement and of systemic inflammation in CD patients with different stages of clinical activity, with a group of healthy subjects.
Methods: thirty CD patients (age 43.10 ± 14.6 yrs) without clinical evidence of pulmonary diseases and 21 non smokers, not atopic healthy controls (age 35.1 ± 13.2 yrs) were enrolled.
Results: bronchial (14.9 ± 10.2 ppb vs 10.1 ± 6.3 ppb, p=0.049) and alveolar FENO (4.4 ± 2.2 ppb vs 2.6 ± 1.9; p=0.006) were significantly higher in CD patients than in healthy controls, respectively. Both bronchial (p=0.0016) and alveolar FENO (p=0.017) were positively correlated with Crohn‘s Disease Activity Index.

Conclusions: our results for bronchial and alveolar FENO confirm subclinical pulmonary involvement in Crohn‘s disease. FENO may be of clinical value during follow-up of these patients as a surrogate marker of systemic inflammation.

Rating:

Share or cite this content

Citations should be made in the following way:
M. Malerba, B. Ragnoli, A. Radaeli, C. Ricci, F. Lanzarotto, A. Lanzini (Brescia, Italy). Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease. Eur Respir J 2011; 38: Suppl. 55, 4779

Member's Comments

No comment yet.

Related content which might interest you: Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Bronchial and alveolar components of exhaled nitric oxide and their relationship Source: Eur Respir J 2012; 39: 1258-1261 Year: 2012 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Value of exhaled nitric oxide in the evaluation of disease activity in sarcoidosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 174s Year: 2002 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Phenotyping symptomatic asthma using proximal and peripheral exhaled nitric oxide Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Increased alveolar concentrations of exhaled nitric oxide (NO) are associated with lung affection in systemic sclerosis (SSc) Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005